On January 7th, a new order was issued on January 7th by the US federal court in regards to the state court testosterone lawsuit proceedings and the twin claims currently being dealt with in many different state courts. The order states that a number of attorneys who represent the plaintiffs must now act as the same with state proceedings held in Illinois, Missouri, Pennsylvania, California and Indiana and also for other state cases that happen in the future. This order may result in settlements ended faster for men injured by these drugs.
An estimated 620 – and growing – “Low T” therapy lawsuits have been filed in the Northern District of Illinois defending men who claim to have suffered strokes, heart attacks, life-threatening cardiovascular events, deep vein thrombosis and pulmonary embolism as a result of their treatment. At the top of the list, the plaintiffs allege that the manufacturers of the prescribed drugs concealed their potentially adverse side effects from the public and did nothing to warn doctors and physicians about the risks so they could inform patients. The plaintiffs also propose that sales of the medications were driven by misleading multi-million dollar marketing claims by pharmaceutical companies that drilled into minds that the drugs were remedies for male aging symptoms. Those claims have now injured healthy men that used the drugs without true medical need and did not have hypogonadism.
Court documents uncover that the “Low T” drug therapy litigation has been getting stronger since January of 2014 when the FDA published a safety announcement stating they were seriously investigating the drugs in question.
ANY OF THE FOLLOWING TESTOSTERONE REPLACEMENT DRUGS COULD BE HARMFUL:
There are a variety of products on the market including gels, patches, pills and injections.
- Android 10®
- Android 25®
FDA advisors have instructed the prescription labels be updated to reflect that the medications have indeed not been proved to lessen muscle loss, fatigue, low libido and other male aging symptoms. The FDA advisors also require manufacturers to conduct heart-related side effect studies on their drugs.
We will see many more lawsuits filed in 2015.